Clinical Trial Update: Efficacy of Soluble Beta-1,3/1,6-Glucan Compared to Placebo on Chronic Leg Ulcers in Diabetes Patients [Phase 2]

View source ↗

Summary

Phase 2 randomized trial evaluating soluble beta-1,3/1,6-glucan versus placebo for healing chronic diabetic foot ulcers; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Foot Ulcer

Drugs mentioned

• Soluble Beta-1,3/1,6-Glucan (soluble beta-1,3/1,6-glucan)

Snippet

Sponsor: Biotec Pharmacon ASA | Conditions: Foot Ulcer | Phase 2 | Status: COMPLETED